Cargando…
Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment
Herbal interactions with nifedipine/felodipine through cytochrome P450 (CYP) 3A inhibition is significant in humans. Shengmai-San (SMS), a three-herbal formula of Chinese medicine, is commonly prescribed in Asia populations for cardiovascular disorders. This study aimed to elucidate the impact of SM...
Autores principales: | Wang, Hong-Jaan, Chia-Hui Tan, Elise, Chiang, Tzu-Yi, Chen, Wei-Ching, Shen, Chien-Chang, Ueng, Yune-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931008/ https://www.ncbi.nlm.nih.gov/pubmed/35647719 http://dx.doi.org/10.38212/2224-6614.3401 |
Ejemplares similares
-
Shenmai-Yin decreased the clearance of nifedipine in rats: The involvement of time-dependent inhibition of nifedipine oxidation
por: Wang, Hong-Jaan, et al.
Publicado: (2018) -
Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein
por: Liang, Yan, et al.
Publicado: (2014) -
Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice
por: Zhao, Juan, et al.
Publicado: (2016) -
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021) -
Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases
por: Liang, Ren-Jong, et al.
Publicado: (2022)